
OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Biosimilar Product

OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico

Cytovia driving CAR NK manufacturing to Puerto Rico
Biosimilar Solutions, Inc. enters License and Development Agreement with Reliance Life Sciences Ltd

Invest Puerto Rico elevates the Island's role as a global bioscience R&D and manufacturing hub attracting two major life-critical investments, $228M in new activity

BioSimilar Corporate Overview

Corona Virus - Real World Experience Directly from Front Lines

Regulatory Convergence -2020 Perspective

Top 10 Takeaways to New about New Biosimilar Interchangeability Guidance

Biosimilar Action Plan Long Way to Go

Game Changer - FDA Biosimilar Action Plan

Clinical Lessons Learn - Biosimilar Programs

Analytical Similarity Gaps and Lessons Learned

Early Considerations for Global Biosimilar Application - Part 1 of 3
